We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
S
6701
DELISTED
Sprint Corporation
S
-447,932
Closed -$3.86M
TLRA
6702
DELISTED
Telaria, Inc.
TLRA
-178,116
Closed -$1.07M
SUMR
6703
DELISTED
Summer Infant, Inc.
SUMR
$0 ﹤0.01%
1
IDXG
6704
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$0 ﹤0.01%
1
SRAX
6705
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
-14,712
Closed -$30K
ONCS
6706
DELISTED
OncoSec Medical Incorporated
ONCS
$0 ﹤0.01%
5
VISL
6707
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$0 ﹤0.01%
2
ELGX
6708
DELISTED
Endologix Inc
ELGX
$0 ﹤0.01%
634
-2,046
-76% -$1.73K
NVIV
6709
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$0 ﹤0.01%
6
CEI
6710
DELISTED
Camber Energy, Inc
CEI
0
WSTL
6711
DELISTED
Westell Technologies Inc
WSTL
$0 ﹤0.01%
180
-150
-45% -$121
EMMS
6712
DELISTED
Emmis Communications Corp
EMMS
-2,001
Closed -$4K
QBAK
6713
DELISTED
Qualstar Corp
QBAK
-2,396
Closed -$6K
CPAH
6714
DELISTED
Counterpath Corp
CPAH
-2,950
Closed -$6K
USLV
6715
DELISTED
VelocitySharesTM 3x Long Silver ETN linked to the S&P GSCI Silver Index ER
USLV
-250
Closed -$9K
KEM
6716
DELISTED
KEMET Corporation
KEM
-388,138
Closed -$9.38M
MNE
6717
DELISTED
Blackrock MUNI New York Intermediate Duration Fund, Inc.
MNE
-20,241
Closed -$296K
LVOXU
6718
DELISTED
LiveVox Holding, Inc. Unit
LVOXU
$0 ﹤0.01%
5
JHME
6719
DELISTED
John Hancock Multifactor Energy ETF
JHME
-59
Closed -$1K
FIYY
6720
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
-90
Closed -$6K
LLEX
6721
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
-3,013
Closed
VRML
6722
DELISTED
Vermillion, Inc.
VRML
-25,718
Closed -$21K
AXJL
6723
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
-7,226
Closed -$383K
BVSN
6724
DELISTED
Broadvision Inc Com
BVSN
-1
Closed
SORL
6725
DELISTED
SORL Auto Parts, Inc.
SORL
-500
Closed -$2K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.